Our previous studies have demonstrated that BLV infection leads to the upregulation of immunoinhibitory molecules PD-1, PD-L1, and TIM-3, and that blocking these molecules can restore T-cell function both in vitro and in vivo [33,34,35]. Here, PDCD1 is linked to deltaretrovirus infections.